Literature DB >> 98779

The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity.

P Jenner, C Pycock, C D Marsden.   

Abstract

Mice with a 6-hydroxydopamine induced unilateral nigro-striatal lesion received (+)-amphetamine sulphate (2.5-20 mg/kg) over a 3-month period by daily incorporation into the drinking water. Druing this period the circling response to apomorphine hydrochloride (0.01-0.5 mg/kg, s.c.) was increasingly suppressed in comparison to control animals, while spontaneous locomotor activity increased. Following drug withdrawal the circling response to apomorphine remained suppressed two months later. However, spontaneous locomotor activity was also reduced up to 1 month following drug removal. The dopamine content of the lesioned side of the forebrain was 25% of the intact side in control animals and was not further reduced by amphetamine administration. The dopamine content of the intact forebrain was reduced by 43% during amphetamine administration and remained 18% depressed 1 month following drug withdrawal. No changes in 5-hydroxytryptamine or noradrenaline concentrations were observed in either the intact or lesioned side. This data, while showing that chronic amphetamine treatment can induce persistent changes in dopamine receptor sensitivity, can be interpreted in terms of increased striatal receptor sensitivity or as a decreased response of dopamine receptors in the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 98779     DOI: 10.1007/bf00426895

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

2.  Effects of motor innervation on the chemical sensitivity of skeletal muscle.

Authors:  S THESLEFF
Journal:  Physiol Rev       Date:  1960-10       Impact factor: 37.312

3.  Tolerance to amphetamine in two species (rat and guinea pig) that metabolize it differently.

Authors:  P S Sever; J Caldwell; R T Williams
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

4.  The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.

Authors:  I Creese; S D Iversen
Journal:  Psychopharmacologia       Date:  1974

5.  Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

Authors:  E H Ellinwood; A Sudilovsky; L M Nelson
Journal:  Am J Psychiatry       Date:  1973-10       Impact factor: 18.112

6.  Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

Authors:  S H Snyder
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

7.  Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.

Authors:  D S Segal; A J Mandell
Journal:  Pharmacol Biochem Behav       Date:  1974 Mar-Apr       Impact factor: 3.533

8.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

9.  Comparative psychotomimetic effects of stereoisomers of amphetamine.

Authors:  B M Angrist; B Shopsin; S Gershon
Journal:  Nature       Date:  1971-11-19       Impact factor: 49.962

10.  The rotating rodent: a two component system?

Authors:  C J Pycock; C D Marsden
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

View more
  2 in total

1.  Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.

Authors:  T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse.

Authors:  A V Juorio
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.